ORIGINAL RESEARCH article
Front. Pharmacol.
Sec. Experimental Pharmacology and Drug Discovery
Ketoprofen-Loaded Quatsomes as a Smart Repurposed Antifungal Therapy for Vaginal Infections: Formulation, Characterization, and Microbiological Evaluation
Provisionally accepted
- 1Cairo University Faculty of Pharmacy, Cairo, Egypt
- 2Karolinska Institutet (KI), Solna, Sweden
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Vulvovaginal candidiasis (VVC) is one of the most common fungal infections requiring more effective and patient-friendly therapies. This study introduces repurposed Ketoprofen (KPN) Quatsomes (QS) as a novel nano-platform for localized antifungal treatment. KPN-QS were prepared using quaternary ammonium surfactants and cholesterol via probe sonication and optimized through a 3¹×2² mixed factorial design using Design-Expert® software. The effects of quaternary ammonium surfactant type (factor A), amount of vesicle-forming materials (factor B), and cholesterol-to-surfactant ratio (factor C) were evaluated to maximize entrapment efficiency and zeta potential, while minimizing particle size. The optimized QS exhibited spherical nano-sized vesicles (113.7 nm) with high entrapment efficiency (96.8%) and strong positive zeta potential (72.5 mV), ensuring stability and enhanced mucosal adhesion. TEM confirmed the spherical morphology, and in vitro release showed biphasic behaviour with 86.5% release after 8 h, alongside excellent storage stability. Repurposing KPN as an antifungal agent significantly enhanced both in vitro and in vivo microbiological efficacy. The formulation displayed promising MIC values against Candida albicans and markedly improved antifungal performance in vivo VVC model. The KPN-QS group exhibited 4.807 and 2.941 log reductions in fungal count compared to the negative control and KPN suspension, respectively, with complete eradication in three rats after 72 h. Histopathological analysis confirmed the safety of QS on vaginal mucosa. Collectively, repurposed KPN-QS constitute a stable, biocompatible nanocarrier for targeted vaginal delivery, demonstrating superior antifungal activity and therapeutic potential in VVC.
Keywords: invivo microbiological model, Ketoprofen, Mixed factorial design, Quatsomes, repurposed drug, Vaginal candidiasis
Received: 14 Dec 2025; Accepted: 03 Feb 2026.
Copyright: © 2026 Eldeeb, Aziza, Hassan, Saher and Ahmed. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Osama Saher
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.